ABT vs WOLF · P/E 25, rev $44.33B vs rev $757.6M
Abbott Laboratories (ABT) versus Wolfspeed Inc (WOLF) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Wolfspeed Inc (WOLF) is a semiconductors company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported WOLF revenue for 2025-06-29 was $757.6M. Net income was -$1.61B. Revenue was down 6.1% from 2024-06-30 to 2025-06-29. WOLF currently screens at market cap $183.6M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. WOLF currently screens at market cap $183.6M.
Not investment advice. Open the ABT and WOLF stock pages for the full models.
Not investment advice.